Stock UniverseDerived research view · source repositories remain read-only

Ascendis Pharma A/S (ASND)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
High
Selection Score
41.51
Global Rank
270
Market Cap
14.33B
Latest Close
210.45
RS Composite
-12.36% · G#2248

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-10.79%
3M
-12.55%
6M
4.96%
1Y
21.16%
3Y
141.98%
5Y
56.61%
10Y
1431.66%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 553.65K · 30-day average: 682.92K · Max drawdown over stored range: -61.72%

Research Snapshot

Relative Strength vs SPX

RS Composite-12.36%
20D RS-15.14%
60D RS-16.47%
120D RS-6.86%
Global RS Rank2248 · 33.00% percentile
Qualified+ RS Rank849 · 32.51% percentile
Group ScopeQualified+
Primary RS Rank226 · 50.66% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank17 / 701
Primary Percentile97.72
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for ASND.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue7.77851.174266.718363.641720.132
Revenue Growth (YoY)11.865%557.933%421.198%36.339%98.034%
Gross Profit4.25539.037222.323319.383625.217
Operating Income-451.792-561.814-455.541-278.763-136.271
Free Cash Flow-441.353-510.188-469.803-307.62445.412
Free Cash Flow Per Share-8.058-9.099-8.347-5.3140.749
EPS (Diluted) GAAP-7.003188-10.400844-8.553422-6.530899-3.762494
EPS Growth
EPS Non-GAAP
Gross Margin54.705%76.283%83.355%87.829%86.82%
Operating Margin-5808.588%-1097.85%-170.795%-76.659%-18.923%
Profit Margin-4931.563%-1139.629%-180.508%-103.972%-31.666%
Free Cash Flow Margin-5674.376%-996.967%-176.142%-84.596%6.306%
Shares Outstanding (Diluted)54.771856.071856.287157.891660.6071
Shares Change (YoY)8.209%2.374%0.384%2.851%4.691%

SEC Quarterly Fundamentals

No processed quarterly rows for ASND.